Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CEO

Chief Financial Officer

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic,...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-30	Premium	bought	Premium	Premium	Premium	-
2024-04-24	Premium	bought	Premium	Premium	Premium	President and CEO
2024-04-23	Premium	sold	Premium	Premium	Premium	-
2024-04-22	Premium	sold	Premium	Premium	Premium	-
2024-04-22	Premium	bought	Premium	Premium	Premium	-
2024-04-09	Premium	acquired	Premium	Premium	Premium	-
2024-03-01	Premium	sold	Premium	Premium	Premium	President and CEO
2024-01-24	Premium	acquired	Premium	Premium	Premium	-
2024-01-16	Premium	bought	Premium	Premium	Premium	-
2023-12-29	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-12-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-11-30	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-11-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-10-31	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-10-13	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-09-30	Premium	acquired	Premium	Premium	Premium	-
2023-09-29	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-09-26	Premium	acquired	Premium	Premium	Premium	-
2023-09-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-08-31	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-08-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-07-31	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-07-19	Premium	bought	Premium	Premium	Premium	-
2023-07-14	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-30	Premium	acquired	Premium	Premium	Premium	President and CEO

GALT - Galectin Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for GALT